EGF Theramed Health Corp.
TMED
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.23M | -2.32M | -2.31M | -294.00K | -292.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11M | 2.12M | 2.11M | 51.90K | 56.20K |
| Change in Net Operating Assets | 54.20K | 81.10K | 230.30K | 272.40K | 233.20K |
| Cash from Operations | -68.20K | -122.90K | 24.50K | 30.20K | -3.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 85.00K | 4.00K | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | -25.80K | -25.80K | -25.80K | -25.80K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.20K | -15.30K | -18.00K | -18.00K | -18.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -7.10K | -138.20K | 6.50K | 12.20K | -21.40K |